Foghorn Therapeutics Inc. Email Format

Biotechnology ResearchMassachusetts, United States51-200 Employees

Foghorn Therapeutics is pioneering the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system, an untapped opportunity for therapeutic intervention. Our proprietary Gene Traffic Control® platform gives us an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing us to identify, validate and potentially drug targets within the system. 

✕

Access Insights for Foghorn Therapeutics Inc. and Millions of Other Companies

Sign up for full access to Foghorn Therapeutics Inc. information. No credit card needed.

Continue with GoogleContinue with Microsoft

OR

Work email

Create AccountBy creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Sign up for free to view info

Company overview Employee directory